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Abstract
Adapting to an over-demanding stressful urban environment may exhaust the psycho-
physiological resources to cope with these demands, and lead to sympathetic nervous
system dysfunction. The evidence that an urban-dwelling lifestyle may be detrimental to
the cardiometabolic health of Africans motivated the design of the Sympathetic activity
and Ambulatory Blood Pressure in African Prospective cohort study. We aimed to deter-
mine neural mechanistic pathways involved in emotional distress and vascular remodel-
ling. The baseline sample included 409 teachers representing a bi-ethnic sex cohort from
South Africa. The study was conducted in 2008–09 and repeated after 3-year follow-up in
2011–12, with an 87.8% successful follow-up rate. Seasonal changes were avoided
and extensive clinical assessments were performed in a well-controlled setting. Data col-
lection included sociodemographics, lifestyle habits, psychosocial battery and genetic
analysis, mental stress responses mimicking daily life stress (blood pressure and haemo-
static, cardiometabolic, endothelial and stress hormones). Target organ damage was
assessed in the brain, heart, kidney, blood vessels and retina. A unique highly pheno-
typed cohort is presented that can address the role of a hyperactive sympathetic nervous
system and neural response pathways contributing to the burden of cardiometabolic dis-
eases in Africans.
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Why was the cohort set up?
Cross-sectional surveys over more than 20 years have dem-
onstrated hyperactive sympathetic nervous system (SNS) re-
sponses in approximately 9000 Blacks (Africans) from the
North-West Province in South Africa.1–4 SNS responses
and prevalence of lifestyle-related diseases were apparent in
urban-dwelling Africans, which underscored the urban en-
vironment as a potent chronic psychosocial stressor.1–4
Other studies support the role of SNS hyperactivity or early
stages of neurogenic hypertension associated with cardio-
metabolic risk markers such as disturbed vascular blood
pressure responses,2 stress hormones,5 inflammation,6 fi-
brinolysis,7 structural wall changes in the left ventricle8 and
sympathovagal disturbance.9 Thus the process of chronic
exposure to psychosocial stress will result in high allostatic
load or overload, which may be detrimental to cardiometa-
bolic health.10 It is possible that prolonged, uncontrollable
psychosocial stress impairs stress appraisal or coping ability
at both physiological and psychological levels, inducing
neural fatigue.2,3 Despite improved medical treatment regi-
mens, the emerging burden of cardiometabolic disease
among urban Black Africans urgently needed an innovative
approach. To date, experimental trials of hypertension
treatment or prospective population studies have not
attempted to explain the role of hyperactive SNS or neural
response pathways (brain) contributing to the cardiometa-
bolic (heart) disease burden in Africans. Therefore, an in-
novative brain-heart link approach motivated the design
of the international Metabolic Syndrome Institute Award-
winning SABPA Project. Our objectives were to conduct
the first psychophysiological prospective cohort study in
sub-Saharan Africa, addressing (i) the brain-heart link and
(ii) neural response pathways to describe plausible mechan-
isms for cardiometabolic morbidity and mortality in a bi-
ethnic cohort including both sexes.
Who is in the cohort?
All teachers (N¼ 2170), enrolled in the 43 schools of the
Dr Kenneth Kaunda Education District (Klerksdorp and
Potchefstroom), North-West Province South Africa, were
invited to participate (Figures 1–2). To control for seasonal
variation of the pro-coagulation markers, only approxi-
mately 200 participants could participate annually
(Figure 3).11 Power analyses were therefore performed for
the SABPA study cohort. Using previous studies, ambula-
tory autonomic dysfunction12 and cortisol data13,14 were
used to obtain relevant effect sizes based on differences in
biological profiles and genotyping hypothalamic-pituitary-
adrenal (HPA) axis variation. Resulting sample sizes of
50–416 would enable explanation of biological differences
and detection of single nucleotide polymorphisms (SNPs)
with a statistical power of 0.8, and level of significance of
0.05.12–14
The target population included urban-dwelling well-
educated Black (African) and White African (Caucasian)
male and female teachers, ensuring participants with simi-
lar socioeconomic standing (Figure 2). All volunteering
teachers had medical aid benefits and were screened to
meet study eligibility criteria during the recruitment phase
(Figure 2). Those complying formed the respondent group
of 409 (Figure 2), and those not complying formed the
non-respondent group (N¼62) (Table 1). The Black teach-
ers preferred to be informed and recruited in separate sex
groups and the protocol, especially the amount of blood
drawn and hair sampling, was not well received. Time con-
straints were the main obstacle for participation in the
Caucasian teachers’ cohort and mixed-sex informed re-
cruitment sessions were not a problem. Data are currently
available for 409 teachers of Phase I from which 359 were
followed up in Phase II.
The SABPA study abode by the institutional guidelines
and terms of the Declaration of Helsinki (revised 2004)
and was approved by the ethics review board of the
North-West University, Potchefstroom Campus (NWU-
0003607S6). Consent and cooperation agreement were
obtained from the Department of Education North-West,
South African Democratic Teacher Unions and Headmas-
ters of Schools. The nature, benefits and risks of the study
were explained in detail in English and native language to
Key Messages
• Cardiometabolic vulnerability was evident in an urban African male cohort.
• The brain-heart link revealed higher sympathetic activity via depressed heart variability, a-adrenergic vascular, silent
ischaemia and attenuated neuroendocrine and psychological distress responses. These findings were associated with
hypertrophic remodelling and compensatory raised ambulatory blood pressure.
• Hypervigilant defensive coping facilitated disturbed cardiometabolic responses: self-reported behavioural ‘in-control’ defen-
sive coping was coupled with physiological ‘loss-of-control’ defensive coping responses. This demonstrates dissociation
between defensive coping behaviour and physiology, which may mask control and induce neural fatigue or ‘burn-out’.
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the involved parties and teachers, and their written in-
formed consent was obtained before participation.
Recruitment was systematically done over a 3-month
period prior to clinical assessments during Phases 1 and 2.
A registered nurse and a trained African fieldworker pro-
vided volunteers with a detailed description of planned
measurements, the protocol and expected outcomes with
an opportunity to ask questions. Participants’ medical his-
tory and treatment information were screened for eligibil-
ity (21.71% of 2170 invited teachers) and, on approval,
for inclusion in the main study. This was followed by the
signing of informed consent forms by all eligible
Figure 1. Geographical location of Klerksdorp and Potchefstroom in the North-West Province, South Africa.
Figure 2. The Sympathetic activity and Ambulatory Blood pressure in Africans (SABPA) prospective cohort study population.
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participants. Clinical assessments were conducted for each
participant over a 2-day period during late summer–late
autumn 2008 and 2009, and 409 participants completed
Phase I (Figure 2). Table 1 compares respondents and non-
respondents in terms of basic variables. Men and Africans
were under-represented in the non-respondent group.
Approximately 19% of all invited teachers (N¼ 2170),
including 44% of all primary school teachers (Grades 1 to
7) participated in the SABPA study (Figure 2, Table 1).
Non-respondents used more medications and demon-
strated more cardiometabolic comorbidities. The differ-
ences almost throughout could be attributed to the tightly
controlled lower comorbidities required for the respondent
group.
How often have they been followed up?
Phase 1 assessment of SABPA was undertaken over a
1-year period in 2008–09. Follow-up (Phase 2) data collec-
tion was completed after 3 years in 2011–12. Contact
between baseline and 3-year follow-up was sustained via
mobile cellular messaging system and feedback workshops
to explain results and referrals. The participants were
encouraged to follow medical prescribed treatment regi-
mens resulting from the study’s clinical assessments. Three
months prior to 3 years after Phase 1, all respondents who
completed Phase I were invited to take part in the follow-
up (Figure 1). The follow-up participation rate was high
(87.8%). The non-respondents (N¼ 62) were encouraged
to enter the service delivery programme of the
Hypertension Research and Training Clinic (on campus)
for ambulatory blood pressure screening. Respondents are
registered teachers, allowing a trained employee and the
principal investigator to keep track of the mortality rates
of the respondent group only, in collaboration with the
North-West Departments of Education and Internal
Affairs. A third follow-up has not been finalized.
What was measured?
The data were collected in a well-controlled overnight fa-
cility at the North-West University in order to habituate
participants to their environment, to avoid the white-coat
effect,15 while maintaining high data quality. Well-
controlled conditions were maintained in assessing optimal
SNS responses during exposure to acute mental laboratory
stressors.16 Individualized health profile reports and refer-
rals were received by each respondent within 1 week after
data collection. Despite the intense clinical assessment pro-
gramme, feedback reports indicated that participants were
comfortable with the experimental setting and 97.8% ex-
pressed their interest for future participation.
Seasonal variations were avoided and gold-standard
methods were applied at both phases, i.e. validated
Figure 3. Mean temperature over the 4-month data collection periods of
the SABPA Prospective cohort study during late summer-late autumn11.
Table 1. Comparing respondents and non-respondents in terms of basic variables
Variables Respondents (N¼409) Non-respondents (N¼62) Difference (95% CI) P-value (t-/X2 tests)
Socio-demographic profile at baseline
Age, years 44.706 9.6 46.39 9.2 1.69 (4.25–0.87) 0.195
Sex, men, n (%) 202 (49.4) 10 (16.1) 33.3 (20.2–46.3) <0.0001
Africans, n (%) 200 (48.9) 15 (24.2) 24.7 (11.5–37.9) 0.0003
Teachers, grades 1–7, n (%) 181 (44.3) 39 (62.9) 18.6 (5.3–31.9) 0.006
Self-reported anthropometric measurements
Body mass index (kg/m2)a 28.856 6.6 30.266 5.0 1.41 (3.13–0.31) 0.108
Self-reported comorbidities at baseline
Cardiovascular disease, n (%) 44 (10.8) 21 (33.9) 23.1 (14.1–32.1) <0.0001
Hypertension drugs, n (%) 96 (23.5) 27 (43.6) 20.1 (8.4–31.7) 0.0008
Diagnosed diabetics, n (%) 12 (2.9) 8 (12.9) 10.0 (4.6–15.3) 0.0003
Epilepsy, n (%) 3 (0.73) 6 (9.68) 9.0 (5.4–12.5) <0.0001
Antidepressant drugs, n (%) 4 (1.0) 33 (53.2) 52.2 (46.8–57.7) <0.0001
Blood donor, n (%) 0 (0.0) 6 (9.7) 9.7 (6.8–12.6) <0.0001
Values are expressed as arithmetic mean or number of participants (%). Differences are expressed as absolute values (95% CI).
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questionnaires, measurements and calibrated apparatus
(Figure 3; Table 2). Repeat measurements were collected at
both phases 1 and 2 of the brain-heart link measures [HPA
and sympathy-adrenal-medullary axis (SAM), renin-
angiotensin-aldosterone system (RAAS), ambulatory blood
pressure and electrocardiogram (ECG), and objectively
assessed lifestyle (Figure 4), neurotrophins, renal function,
metabolism, pro-inflammatory, pro-thrombotic, functional
and structural endothelium]. The psychosocial battery was
completed under supervision of bi-ethnic clinical psycholo-
gists. Psychophysiological stress tasks, namely the Cold
Pressor and the Stroop Word-Colour Conflict (Stroop)
tests16 were administered at phase I and were applied for
1 min in a counterbalanced design. For blood sampling, a
sterile winged infusion set was left in situ with a heparin
block to prevent clotting (0.5 ml of heparin sodium-frese-
nius 5000 IU/ml in 50 ml normal saline solution; Fresenius
Kabi, Port Elizabeth, South Africa). The infusion set was
thoroughly flushed with 2–3 ml saline and the first 2 ml of
blood discarded, before sampling was done for coagulation
measures. For each task, beat-to-beat blood pressure and
12-lead ECG were assessed throughout stress testing fol-
lowed by a 10-min recovery period. Blood (total 150 ml)
and saliva sampling (total 6 ml) was done at rest and at 10
and 30 min post-task, respectively. Participants received a
monetary incentive according to performance during com-
pletion of the Stroop task as motivation to excel, and per-
ception of stressors was scored. A medical doctor was
available for adverse events. Additional measurements at
phase 2 included 24-h diet, 24-h urine, 7-day objective
physical activity status, differentiated blood cell count,
genetic damage, microvascular (retinal) endothelial func-
tion under mydriatic conditions, and chronic stress (hair
samples) (Table 2).
What has been found?
A complete list of collaborators and publications from
the SABPA Study can be found at http://stressed-project.
co.za/data-dissemination/.
The overarching aim of the study was to assess the
interaction between brain and cardiometabolic responses
(brain-heart link) and the neural response pathways in a
bi-ethnic cohort including both sexes in order to provide
estimates of the proportion of individuals at high risk of fu-
ture vascular events. We have demonstrated that objective
lifestyle risk factors, such as alcohol misuse, mostly
explained differences in blood pressure, the metabolic syn-
drome and sub-clinical vascular disease between Black and
White South Africans.18–20 Among Black Africans we
observed disturbed sympathovagal balance suggestive of
sympathetic activity modulation, augmented a-adrenergic
vascular, pro-coagulant, attenuated nitric oxide metabo-
lite, stress hormone and emotional distress responses.20–29
These factors potentiate adrenergic drive and reinforce
metabolic overdrive and structural alterations.20–29
Diminished ß-adrenergic responsiveness was previously
suspected in urban Africans2 and is again demonstrated by
the increased 24-h BP, augmented a-adrenergic responses
and associated vascular hypertrophy in the SABPA co-
hort.20,24–27 Moreover, our findings complement a notion
of autonomic dysfunction via depressed heart rate variabil-
ity and early structural vascular changes in African men,
mostly facilitated by hypervigilant defensive coping.20–22,27
These structural vascular changes could counteract sympa-
thetic vasoconstriction and contributed to their stress-
induced ischaemia.20 This will thus impair neuronal re-up-
take of norepinephrine, thereby potentiating sympathetic
signalling. Indeed, reduced perfusion of the heart was
observed with a higher prevalence of silent ischaemic
Figure 4. Obtaining anthropometric (4a) and 24h ambulatory blood pressure and 24h ECG (including heart rate variability) measures (4b) during the
SABPA Prospective Cohort study data collection phases.
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Table 2. Summary of brain-heart clinical assessments and apparatus
Assessments 2008–09 2011–12
Medical history & related questionnaires: H H
Duration of stay, education, marital status, alive family members, health (cardiometabolic, inflammation, de-
pression, renal, arthritis, cancer, reproduction), sleep apnoea, ambulatory & dietary diary, mental stress
perception
Feedback of results (incl. referrals and incident findings): H H
Individual & group
Chronic medications
Nervous system, kidney, hypertension, arrhythmia, diabetes, coagulants, hormones, inflammation, analgesics,
depression/anxiety, proton pump, epilepsy, supplements
H H
Lifestyle
Objective & self-reported smoking & alcohol habits H H
Diet, standardized dinner & breakfast H H 24-h
Anthropometry (height, body mass, waist and neck circumferences) H H
Number of times measured (Invicta Stadiometer IP 1465, Precision Health Scale, A & D Company Holtain
7-mm wide metal tape)
3 3
Objective total energy expenditure (ActicalVR Mini Mitter, Bend OR; 7-days Actiheart, CamNtech Ltd) H H 7-day
Changes in lifestyle habits over time H
Psychosocial battery
Measures with known heritability: life orientation, personality H X
Predictors of development/worsening of hypertension: coping, depression, cognitive distress H H
Measures which could moderate the effects of environment: fortitude, mental health, self-regulation, job stress H H
Cardiovascular assessment
Resting BP & 12-lead ECG (Riester CE 0124VR &1.3M TM LittmanVR II S.E. Stethoscope 2205; Finometer,
Finapres Medical SystemsVR ; NORAV PC-ECG 1200VR )
aH H
24-h ambulatory BP & -ECG (CardiotensVR & Cardiovisions 1.19VR , Meditech) H H
Biochemical assessments (trained technicians; accredited laboratories)
Bodily fluids sampling times (urine, blood, saliva) H H
Serum brain-derived neurotrophic factor H H
Serum cotinine (smoking) and liver enzymes (alcohol misuse) H H
Differentiated blood count X H
Serum electrolytes H H
Serum oxidative stress aH H
Citrate haemostasis aH H
Plasma inflammatory profile, H H
Plasma essential amino acids H H
Plasma renin-angiotensin-aldosterone system, endothelial function (L-arginine-NO synthase) aH H
Urine/blood/saliva HPA & SAM axis hormones, serotonin aH H hair
Whole blood HIV status (PMC Medical, Daman, India), Pareekshak test (BHAT Bio-Tech, Bangalore, India) H H
Retinal vessel analysis X H
Static & dynamic measures (incl. dynamic saliva stress hormone responses) (DVA PLUS 12100003VR , Imedos)
Intraocular eye pressure X H
(TONO-PEN-AVIAVR Applanation Tonometer CE 0120, Reichert)
Ultrasound carotid intima-media thickness (CIMT) bH H
(Sonosite MicromaxxVR , SonoSite Inc., Bothell, WA)
DNA genome (PCR based)
Nuclear & mitochondrial genome sequencing H
SNP analyses, epigenetics H H
Telomere length H
Metabolism aH H
Serum lipogram & insulin, NaF glucose, urine metabonomics
Renal function H H 24-h
Serum creatinine & 8-h urine
X, no measures.
aIncluding sympathetic nervous system (SNS) responses (1-min exposure to mental stress (Cold Pressor & Stroop Colour-Word-Conflict tests).
bCIMT, plaque score and stenosis at optimal angles obtained from baseline.17
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events in hypervigilant defensive coping African men, espe-
cially if low testosterone levels prevail, i.e. 9.5 events [95%
confidence interval (CI): 5.1-14.0] vs 1.5 (0.0-5.3) when
compared with Caucasian counterparts.20–21,27–28
Overall, cardiometabolic vulnerability was more evi-
dent in African men compared with African women and
Caucasian men and women,18–31 particularly when utiliz-
ing defensive coping.20–22,27 Behavioural and physiological
defensive coping relates to active problem-solving and
primitive ‘fight’, in-control, positive affect33 and eliciting
ß-adrenergic responses,32,33 whereas emotional avoidance
coping relates to defeat, ‘flight’ or loss-of-control re-
sponses, which have been associated with poorer well-
being and an a-adrenergic response profile.32,33 However,
our findings contradict this notion as African men reported
behavioural defensive coping ‘in-control’ responses
coupled with physiological emotional avoidance ‘loss-of-
control’ responses.20–22,27 Indeed, they revealed more
metabolic syndrome markers, attenuated stress hormone
levels and autonomic dysfunction.20–22,27 An apparent dis-
sociation evidently occurs between behavioural and
physiological defensive coping responses suggesting ‘loss-
of-physiological control’. It could further imply that an
overly taxing situation or challenging environment, where
chronic stress is experienced, may mask control.
Subsequent exhaustion of ‘physiological’ resources may
occur when control cannot be exerted.20–22,27
Another urgent matter, at the heart of the rising meta-
bolic syndrome epidemic, was the lack of ethnic-specific
cut-points for central obesity in prospective studies. We
addressed this crucial matter and an ethnic-specific waist
circumference (WC) cut-point model for Africans was pro-
posed.19,30 The model was validated by utilizing diagnostic
tests and non-linear analyses.19 Furthermore, supporting
the brain-heart link, we revealed that the validated eth-
nic-specific WC cut-point model (African men, 90 cm;
-women, 98 cm) was associated with cognitive emotional
distress and sub-clinical atherosclerosis.30
Preliminary causal analyses are progressing and thus
far receiver operating characteristic (ROC) WC cut-point
models strongly support the use of only WC and blood
pressure as predictors of the metabolic syndrome.30–31
McNemar’s case-control test was used to calculate change
in risk (unpublished, Figure 5). We demonstrated no
change in risk for behavioural defensive coping responses
{4.21% change, P¼ 0.147 [odds ratio (OR) 1.39, 95% CI:
0.90-2.15]}. Pertaining to physiological responses, we
observed a decreased trend for autonomic dysfunction
[5.38%, P¼0.051 (OR 0.64, 95% CI: 0.40-1.00)], but
no change in risk for a hypertensive state [3.62%,
P¼ 0.313 (OR 0.71, 95% CI: 0.43-1.14)] or usage of
hypertension drugs [1.95%, P¼ 0.313 (OR 1.22, 95% CI:
0.74-2.01)]. Increased risk was however revealed for waist
circumference [8.64%, P<0.0001 (OR 3.58, 95% CI:
1.86-7.47)] and type 2 diabetes (6.98%, P< 0.0001) (OR
13.5, 95% CI: 3.4-117.1)]. Findings underscore chronic
behavioural defensive ‘in-control’ responses, which were
accompanied by physiological pathological changes, pos-
sibly indicating ‘loss-of-control’ responses. The ongoing
challenge will be to describe neural response pathway
mechanisms for cardiometabolic morbidity and mortality
from a dissociative stress perspective.
What are the main strengths and
weaknesses of the study?
Main weaknesses include the relatively small sample size,
which was restricted in order to control for seasonal vari-
ation. Additionally, the requirement for an overnight stay
and 2 days of testing likely may have had a considerable
restrictive effect on the initial response rate. Potential limita-
tions are biases of initial non-response or attrition over
time. Key strengths are the generation of a unique highly
phenotyped cohort in a well-controlled research setting.
A complex set of gold-standard measures were obtained in
the first psychophysiological prospective cohort study in
Figure 5. Cardiometabolic risk markers presenting change in risk over 3 years in the SABPA Prospective cohort. Heart rate variability (HRV) suggests
increased autonomic dysfunction (standard deviation R-R interval, 50-100 ms); Waist circumference, Joint Interim Statement34.
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sub-Saharan Africa. The focus in this study is on SNS activ-
ity contributing to cardiometabolic disease and emotional
distress. Current findings address the original SABPA design
and problem statement and prospective findings may con-
firm the American Heart Association 2014 statement35 that
depression needs to be considered as a risk factor in pre-
ventive cardiology.
Storage and information about the data set?
Where can I get hold of the data or find
out more?
The cohort data and samples are embedded in a single
large regional research centre at the study research institute
of the Hypertension in Africa Research Team, North-West
University (Potchefstroom Campus), South Africa. Data
are password protected and electronic participant records
are stored for a maximum of 20 years in the secured facil-
ity. The electronic records have been flagged to facilitate
ease of contact and follow-up. Therefore, in addition to
the measures that were undertaken, it will be possible to
access measurements undertaken at both phases 1 and 2.
To ensure maximum data dissemination, all national and
international expert collaborators signed a contract
(memorandum of understanding) for sharing of data and
author input. Participant confidentiality was maintained
under all circumstances. Potential collaborators are invited
to contact the corresponding author and principal investi-
gator at [leone.malan@nwu.ac.za]. Any requests to use the
data will be reviewed by HART.
Funding
This work was financially supported by: the Metabolic Syndrome
Institute France; and the North-West University, Medical Research
Council, National Research Foundation, PA & Alize Malan Trust,
North-West Department of Education and Roche Diagnostics, South
Africa. The funding organizations played no role in the design or con-
duct of the study; collection, management, analysis and interpretation
of the data; or preparation, review or approval of the manuscript.
Acknowledgements
The SABPA study would not have been possible without the volun-
teering participant sample, the dedicated input of the Hypertension
in Africa Research Team (HART), G.J. Motlhasedi (fieldworker), C.
Lessing (research nurse), S. Pe´ter and in-kind analyses of the na-
tional and international teams.
Conflict of interest: None declared.
References
1. Malan NT, Brits JS, Eloff FC et al. The influence of acculturation
on endocrine reactivity during acute stress in urban black males.
Stress Med 1994;2:55–63.
2. Malan L, Schutte AE, Malan NT et al. Specific coping strategies
of Africans during urbanization: comparing cardiovascular re-
sponses and perception of health data. Biol Psych 2006;72:
305–10.
3. Malan L, Malan NT, Wissing MP, Seedat YK. Coping with ur-
banization: A cardiometabolic risk? Biol Psych 2008;79:323–28.
4. Van Rooyen JM, Huisman HW, Eloff FC et al. Cardiovascular
reactivity in black South-African males of different age groups:
The influence of urbanization. Ethn Dis 2002;12:69–75.
5. Schommer N, Helhammer DH, Kirschbaum C. Dissociation be-
tween reactivity of the hypothalamus-pituitary-adrenal axis and
the sympathetic-adrenal-medullary system to repeated psychoso-
cial stress. PsychosomMed 2003;65:450–60.
6. Hamer M, Gibson EL, Vuononvirta R, Williams E, Steptoe A.
Inflammatory and haemostatic responses to repeated mental
stress: Individual stability and habituation over time. Brain
Behav Immun 2006;20:456–59.
7. von Ka¨nel R, Kudielka BM, Helfricht S et al. The effects of as-
pirin and nonselective beta blockade on the acute prothrombotic
response to psychosocial stress in apparently healthy subjects.
J Cardiovasc Pharmacol 2008;51:231–38.
8. Schlaich MP, Kaye DM, Lambert E, Sommervilee M, Socratous
F, Esler MD. Relation between cardiac sympathetic activity and
hypertensive left ventricular hypertrophy. Circulation 2003;108:
560–65.
9. Thayer JF, Lane RD. The role of vagal function in the risk for
cardiovascular disease and mortality. Biol Psych 2007;74:
224–42.
10. Mc Ewen BS: Protection and damage from acute and chronic
stress: allostasis and allostatic overload and relevance to the
pathophysiology of psychiatric disorders. Ann N Y Acad Sci
2004;1032:1–7.
11. TuTiempo. Climate. http://www.tutiempo.net/en/Climate/
POTCHEFSTROOM/02-2008/683500.htm (17 July /2014, date
last accessed).
12. Kohara K, Nishida W, Maguchi M, Hiwida K. Autonomic
nervous function in non-dipper essential hypertensive
participants: evaluation by power spectral analysis of heart rate
variability. Hypertension 1995;26:808.
13. Rogausch A, Kochen MM, Hennig J. Association between the
Bcl glucocorticoid receptor polymorphism and smoking in a
sample of patients with obstructive airway disease. Add Biol
2006;12:93–99.
14. Sato N, Suzuki N, Sasaki N et al. Corticotropin-releasing hor-
mone receptor 1 gene variants in irritable bowel syndrome. PLoS
One 2012;7:e42450.
15. Obrist PA. Cardiovascular psychophysiology: A perspective.
New York, NY: Plenum Press, 1981.
16. Kamarck TW, Lovallo WR. Cardiovascular reactivity to psycho-
logical challenge: conceptual and measurement considerations.
PsychosomMed 2003;65:9–21.
17. Liang YL, Teede H, Kotsoupoulos D et al. Non-invasive meas-
urements of arterial structure and function: repeatability, inter-
relationships and trial samples size. Clin Sci 1998;95:669–79.
18. Hamer M, Malan L. Sympathetic nervous activity, depressive
symptoms, and metabolic syndrome in black Africans: the
Sympathetic Activity and Ambulatory Blood Pressure in Africans
study. Stress 2012;15:562–68.
8 International Journal of Epidemiology, 2014, Vol. 0, No. 0
 at U
CL Library Services on M
arch 26, 2015
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
19. Botha J, De Ridder H, Potgieter JC, Steyn HS, Malan L.
Structural vascular disease in Africans: Performance of ethnic-
specific waist circumference cut points using logistic regression
and neural network analyses: the SABPA study. Exp Clin
Endocrinol Diabetes 2013;121:441–47.
20. Malan L, Hamer M, Schlaich MP et al. Facilitated defensive cop-
ing, silent ischaemia and ECG left-ventricular hypertrophy: the
SABPA study. J Hypertens 2012;30:543–50.
21. Malan L, Hamer M, Schlaich MP et al. Defensive active coping fa-
cilitates chronic hyperglycemia and endothelial dysfunction in
African men: the SABPA study. Int J Cardiol 2013;168:999–1005.
22. De Kock A, Malan L, Hamer M, Malan NT. Defensive coping
and subclinical vascular disease risk – associations with auto-
nomic exhaustion in Africans and Caucasians: the SABPA study.
Atherosclerosis 2012;225:438–43.
23. Hamer M, Malan L, Malan NT et al. Objectively assessed health
behaviors and sub-clinical atherosclerosis in black and white
Africans: the SABPA study. Atherosclerosis 2011;215:237–42.
24. Huisman HW, Schutte AE, Schutte R et al. Exploring the link be-
tween cardiovascular reactivity and end-organ damage in
African and Caucasian men: the SABPA study. Am J Hypertens
2013;26:68–75.
25. Reimann M, Hamer M, Malan NT et al. Autonomic responses to
stress in Black versus Caucasian Africans: the SABPA study.
Psychophysiology 2012;49:454–61.
26. Uys AS, Malan L, Van Rooyen JM, Steyn HS, Reimann M,
Ziemssen T. Attenuated NOx responses and myocardial ische-
mia, a possible risk for structural vascular disease in African
men: the SABPA study. J HumHypertens 2014;28:438–43.
27. Malan L, Hamer M, Schlaich MP et al. Defensive coping facili-
tates higher blood pressure and early sub-clinical structural vas-
cular disease via alterations in heart rate variability: the SABPA
study.Atherosclerosis 2013, 227:391–97.
28. Malan NT, von Ka¨nel R, Schutte AE et al. Testosterone and
acute stress are associated with fibrinogen and von Willebrand
factor in African men: the SABPA study. Int J Cardiol 2013;168:
4638–42.
29. Von Ka¨nel R, Hamer M, Malan NT, Scheepers JD, Meiring M,
Malan L. Procoagulant reactivity to laboratory acute mental
stress in Africans and Caucasians, and its relation to depressive
symptoms: the SABPA Study. ThrombHaem 2013;110:977–86.
30. Botha J, Malan L, Potgieter JC, Steyn HS, De Ridder JH.
Association of waist circumference with perception of own
health in a group of urban African males and females: the
Sympathetic Activity and Ambulatory Blood Pressure in Africans
(SABPA) study. J Endocrinol Metab Diabetes SA 2012;17:106.
31. Hoebel S, Malan L, Botha J, Swanepoel M. Optimizing waist cir-
cumference cut-points for the metabolic syndrome and its com-
ponents in a South African cohort at 3 year follow-up: the
SABPA prospective cohort. Endocrine 2014. doi: 10.1007/
s12020-014-0237-7.
32. Amirkhan JH. A factor analytically derived measure of coping:
The Coping Strategy Indicator. J Pers Soc Psychol 1990;59:
1066–74.
33. Updegraff JA, Gable SL, Taylor SE. What makes experiences sat-
isfying? The interaction of approach-avoidance motivations and
emotions in well-being. J Pers Soc Psychol 2004;86:496–504.
34. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the
metabolic syndrome: a joint interim statement of the International
Diabetes Federation Task Force on Epidemiology and Prevention;
National Heart, Lung, and Blood Institute; American Heart
Association; World Heart Federation; International
Arteriosclerosis Society; and International Association for the
Study of Obesity.Circulation 2009;120:1640–45.
35. Lichtman J, Froelicher ES, Blumenthal JA, Carney RM, Doering
LV, Frasure-Smith N et al. Depression as a risk factor for poor
prognosis among patients with acute coronary syndrome: sys-
tematic review and recommendations. a scientific statement
from the American Heart Association. Circulation 2014;129:
1350–69.
International Journal of Epidemiology, 2014, Vol. 0, No. 0 9
 at U
CL Library Services on M
arch 26, 2015
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
